These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ranibizumab Alters Levels of Intraocular Soluble Cytokine Receptors in Patients with Diabetic Macular Edema. Coughlin BA; Guha-Niyogi P; Sikorskii A; Glazer LC; Mohr S Curr Eye Res; 2020 Apr; 45(4):509-520. PubMed ID: 31488015 [No Abstract] [Full Text] [Related]
6. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion. Wen J; Jiang Y; Zheng X; Zhou Y Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235 [TBL] [Abstract][Full Text] [Related]
7. Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection. Lim JW; Han JR Clin Exp Ophthalmol; 2011 Aug; 39(6):537-44. PubMed ID: 21819507 [TBL] [Abstract][Full Text] [Related]
8. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema. Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223 [TBL] [Abstract][Full Text] [Related]
9. The Influence of Intravitreal Ranibizumab on Inflammation-associated Cytokine Concentrations in Eyes With Diabetic Macular Edema. Lim SW; Bandala-Sanchez E; Kolic M; Rogers SL; McAuley AK; Lim LL; Wickremasinghe SS Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5382-5390. PubMed ID: 30452591 [TBL] [Abstract][Full Text] [Related]
10. Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema. Shiraya T; Kato S; Araki F; Ueta T; Miyaji T; Yamaguchi T PLoS One; 2017; 12(3):e0174340. PubMed ID: 28346545 [TBL] [Abstract][Full Text] [Related]
11. Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema. Payne JF; Clark WL; Bruce BB; Wykoff CC; Brown DM; Menke BM; Iverson SM; Allen KF; Boyer DS; Ophthalmology; 2018 Aug; 125(8):1304-1306. PubMed ID: 29729809 [No Abstract] [Full Text] [Related]
12. VEGF inhibitors for AMD and diabetic macular edema. Med Lett Drugs Ther; 2015 Mar; 57(1464):41-2. PubMed ID: 25758545 [No Abstract] [Full Text] [Related]
13. Functional-morphological parameters, aqueous flare and cytokines in macular oedema with branch retinal vein occlusion after ranibizumab. Noma H; Mimura T; Yasuda K; Shimura M Br J Ophthalmol; 2017 Feb; 101(2):180-185. PubMed ID: 27073207 [TBL] [Abstract][Full Text] [Related]
15. Analysis of cytokines in the aqueous humor during intravitreal Ranibizumab treatment of diabetic macular edema. de Freitas LGA; Isaac DLC; Abud MB; Segundo ADSQ; Barros MLA; de Albuquerque GCM; Guimarães BDA; de Morais CNL; de Ávila MP Sci Rep; 2021 Dec; 11(1):23981. PubMed ID: 34907265 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular involvement in patients with diabetic macular oedema treated with intravitreal ranibizumab in routine clinical practice. Díaz-Rodríguez R; Abreu-González R; Dolz-Marco R; Gallego-Pinazo R Arch Soc Esp Oftalmol; 2017 Jul; 92(7):302-306. PubMed ID: 28110972 [TBL] [Abstract][Full Text] [Related]
17. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151 [TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial. Călugăru D; Călugăru M Ophthalmic Surg Lasers Imaging Retina; 2018 Mar; 49(3):160. PubMed ID: 29554381 [No Abstract] [Full Text] [Related]
19. Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion. Noma H; Mimura T; Yasuda K; Nakagawa H; Motohashi R; Kotake O; Shimura M Ophthalmologica; 2016; 236(4):228-234. PubMed ID: 27832655 [TBL] [Abstract][Full Text] [Related]